ATAC ('Arimidex', Tamoxifen, Alone or in Combination) trial-anastrozole is superior to tamoxifen as adjuvant treatment in postmenopausal women with early breast cancer.

被引：0
|
作者：
Bianco, R [1 ]
机构：
[1] Univ Naples Federico II, Naples, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2002年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
632
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [11] The 'Arimidex', Tamoxifen, Alone or in Combination (ATAC) Trial: A Step Forward in the Treatment of Early Breast Cancer
    Howell, Anthony
    REVIEWS ON RECENT CLINICAL TRIALS, 2006, 1 (03) : 207 - 215
  • [12] Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer
    Houghton, J
    Baum, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S83 - S83
  • [13] Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial (vol 359, pg 2131, 2002)
    Fodor, J
    Borrego, MR
    LANCET, 2002, 360 (9344): : 1520 - 1520
  • [14] Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer
    Baum, M
    Houghton, J
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S39 - S39
  • [15] Adjuvant Sequencing of Tamoxifen and Anastrozole Is Superior to Tamoxifen Alone in Postmenopausal Women with Low Proliferating Breast Cancer
    Bago-Horvath, Zsuzsanna
    Rudas, Margaretha
    Dubsky, Peter
    Jakesz, Raimund
    Singer, Christian F.
    Kemmerling, Ralf
    Greil, Richard
    Jelen, Andrea
    Boehm, Gerhard
    Jasarevic, Zerina
    Haid, Anton
    Gruber, Christine
    Poestlberger, Sabine
    Filipits, Martin
    Gnant, Michael
    CLINICAL CANCER RESEARCH, 2011, 17 (24) : 7828 - 7834
  • [16] Molecular markers in the endometrium at baseline of postmenopausal patients with early breast cancer in the ATAC (Arimidex, tamoxifen, alone, or in combination) trial
    Duffy, SRG
    Taylor, L
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (06) : 1921 - 1927
  • [17] Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
    Howell, A
    Cuzick, J
    Baum, M
    Buzdar, A
    Dowsett, M
    Forbes, JF
    Hoctin-Boes, G
    Houghton, I
    Locker, GY
    Tobias, JS
    LANCET, 2005, 365 (9453): : 60 - 62
  • [18] The ATAC ('Arimidex', Tamoxifen, alone or in combination) early breast cancer trial in postmenopausal patients: endometrial sub-protocol results
    Duffy, S
    Jackson, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 137 - 138
  • [19] 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer-efficacy overview
    Buzdar, AU
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5): : 399 - 403
  • [20] Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: A US healthcare system perspective. The 5-year completed treatment analysis of the ATAC ('Arimidex', Tamoxifen Alone or in Combination) trial
    Locker, Gershon Y.
    Mansel, Robert
    Cella, David
    Dobrez, Deborah
    Sorensen, Sonja
    Gandhi, Sanjay K.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 (02) : 229 - 238
12345